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Abstract
We have studied the function of the zinc finger transcription factor gata3 in auditory system development by analysing
temporal profiles of gene expression during differentiation of conditionally immortal cell lines derived to model specific
auditory cell types and developmental stages. We tested and applied a novel probabilistic method called the gamma Model
for Oligonucleotide Signals to analyse hybridization signals from Affymetrix oligonucleotide arrays. Expression levels
estimated by this method correlated closely (p,0.0001) across a 10-fold range with those measured by quantitative RT-PCR
for a sample of 61 different genes. In an unbiased list of 26 genes whose temporal profiles clustered most closely with that
of gata3 in all cell lines, 10 were linked to Insulin-like Growth Factor signalling, including the serine/threonine kinase Akt/
PKB. Knock-down of gata3 in vitro was associated with a decrease in expression of genes linked to IGF-signalling, including
IGF1, IGF2 and several IGF-binding proteins. It also led to a small decrease in protein levels of the serine-threonine kinase
Akt2/PKBb, a dramatic increase in Akt1/PKBa protein and relocation of Akt1/PKBa from the nucleus to the cytoplasm. The
cyclin-dependent kinase inhibitor p27kip1, a known target of PKB/Akt, simultaneously decreased. In heterozygous gata3 null
mice the expression of gata3 correlated with high levels of activated Akt/PKB. This functional relationship could explain the
diverse function of gata3 during development, the hearing loss associated with gata3 heterozygous null mice and the
broader symptoms of human patients with Hearing-Deafness-Renal anomaly syndrome.
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Introduction
Numerous regulatory genes have been implicated in the
development of many tissues, including the inner ear [1,2,3,4],
but identification of the intracellular systems that they regulate
remains a considerable challenge [5]. This challenge is com-
pounded because a given gene may regulate several molecular
events in different cell types during different developmental stages.
Consequently, functional analysis should be done at cellular
resolution during specified time windows. To achieve this in an
organ as complex as the inner ear we have derived conditionally
immortal epithelial and neuronal cell lines that have been
characterised with a wide range of structural and functional
markers with reference to their counterparts in vivo [6,7,8]. These
cell lines can be differentiated in vitro and screened with whole
genome oligonucleotide arrays to determine temporal profiles of
gene expression. Assuming that functionally related genes are
likely to share similar temporal expression profiles [9] we can
explore such datasets to identify the influence that a given
regulatory gene exerts on gene networks and intracellular systems.
Whilst such information does not identify direct transcriptional
targets it should provide valuable insight into the genetic
regulation of cell behaviour.
The value of this approach depends very heavily on the rigor of
the primary analysis of the array hybridisation signals. Given the
biological variability and high level of noise in this kind of dataset
we have developed probabilistic models, namely the gamma
Models for Oligonuceotide Signals (gMOS), that provide a robust
estimate of expression level along with a measure of uncertainty
for each gene [10]. We have assessed the performance of gMOS
on a biological dataset by re-analysing temporal expression profiles
in an epithelial cell line derived from the cochlear duct of a mouse
inner ear at embryonic day E13.5 [11]. Here we include new
datasets from another epithelial cell line derived from the ventral
otocyst at E10.5 that expresses key sensory cell markers during
differentiation in vitro [6] and from one that expresses critical
markers for cochlear neuroblasts [8].
We focus our analysis on the zinc finger transcription factor
gata3 [12,13] for several reasons. First, it is an early regulator of
auditory system development [14,15] and is expressed in
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numerous cell types including sensory and non-sensory epithelial
cells, efferent and afferent auditory neurons and periotic
mesenchyme [14,15,16,17]. Null mice die in mid embryonic
development [12] and although a small otic vesicle forms it lacks a
cochlear duct, semicircular canals and auditory ganglion [14].
There is direct evidence that gata3 regulates the expression of
fibroblast growth factor 10 (fgf10) in the otic placode [18,19].
Nevertheless, the expression patterns in vivo suggest that it has a
more fundamental role in cell signaling [15]. All of the cell lines
used in this work were selected for expression of gata3 and provide
an opportunity to explore its function at a cellular level. The
second reason for studying gata3 is that haploinsufficiency causes
severe hearing loss in man [20,21,22] and heterozygous null mice
suffer a hearing loss of about 30dB from the onset of hearing with
a progressive, degenerative loss of sensory hair cells and spiral
ganglion neurons [23]. This dose-dependency should increase the
chances of identifying functionally associated genes by clustering
temporal profiles of gene expression. Third, the expression of gata3
is conserved amongst vertebrates and also occurs in T-lympho-
cytes, endothelial cells, placenta, kidney, adrenal gland, hair
follicles and parts of the peripheral and central nervous systems
[24,25,26,27,28]. Thus our results could be relevant to the
development of many other tissues.
The results validate our application of gMOS models to real
biological datasets from oligonucleotide arrays and have allowed
us to establish entirely objective, ranked lists of genes clustered
with gata3 in each of 3 cell lines. A final list was prepared by
selecting those genes that were most highly ranked in all cell lines
under all culture conditions. The results reveal a previously
unknown functional link to insulin-like growth factor signaling and
to the serine/threonine kinase Akt/PKB, which is a hub signaling
molecule for a number of tyrosine kinase receptors [29]. This may
explain elements of the mechanism by which gata3 might
‘orchestrate the regulation of different signaling pathways’ [26]
and co-ordinate the development of the auditory system and other
tissues, including the eye and central nervous system.
Results
Performance of gMOS and mgMOS for the analysis of
gene expression data
Three main datasets were used in this study. They were taken
from cells cultured for 14 days under differentiating conditions.
The first included 12 time points for the epithelial cell line UB/
OC-1 (OC-1), which was derived from organ of Corti at
embryonic day E13.5 and cultured with 10% serum. This dataset
is composed of 24 .CEL files with two chips (Affymetrix
GeneChipH MU11k A and MU11k B) covering 11,000 genes of
the mouse genome and originally analysed with Microarray
Analysis Software MASv.5 [11]. The second dataset included 6
time points for the epithelial cell line US/VOT-E36 (VOT-E36),
which was derived from the ventral part of the otic vesicle at E10.5
and cultured in serum-free media [6]. It was produced from 6
hybridisations to the Affymetrix GeneChipH Mg_U74Av2 for a
total of six .CEL files. The third was a joint set taken only at 0 days
and 14 days from VOT-E36 and US/VOT-N33 (VOT-N33)
cultured with 10% serum [7] and hybridised on Affymetrix
GeneChipH MU11k A and MU11k B (eight .CEL files). Whilst
OC-1 and VOT-E36 represent epithelial cells at different
developmental stages, VOT-N33 was derived from auditory
neuroblasts at E10.5 [8]. The analysis was thus based upon 38
.CEL files representing 22 different cell preparations and three
different array platforms. The datasets for the full temporal profiles
have been deposited in the National Centre for Biotechnology
Information (NCBI) Gene Expression Omnibus Database (http://
www.nvbi.nlm.nih.giv/geo) under the accession numbers GSE36
and GSE15585.
We required a model that would estimate hybridization signals
as accurately as possible with a robust estimate of the background,
particularly those signals expressed at low levels, and that would
provide a measure of uncertainty for each probe-set or transcript.
The ability to do this also facilitates the need to merge data from
different GeneChip platforms. Thus we chose to test the
application of the gamma Model for Oligonucleotide Signals
(gMOS) [10] and the subsequent modification, mgMOS [30,31].
These probabilistic models provide estimates for the variance and
credibility interval for each transcript and generate more accurate
estimates of low levels of gene expression on benchmark datasets
when compared with other stochastic models (Text S1). They were
developed for the specific questions addressed in this study and
have evolved into a more complete package for analysis of
microarray data. They are now integrated into Bioconductor
(http://www.bioconductor.org) in the package puma [32], an open
source and open development software project for the analysis of
genomic data.
We compared the temporal expression profile for gata3 derived
by Taqman qRT-PCR from the cell line OC-1 with the same
samples hybridized to the MU11k GeneChips and analysed with
either gMOS, mgMOS, MASv.5 or Robust Microarray Analysis
(RMA). The results from RMA were obtained with a single call of
the algorithm in which all of the files were processed together. The
qRT-PCR profile showed that gata3 was expressed at very low
levels before day 7, peaked at days 8–9 and then decreased to
about half of the peak value by day 14 (Fig. 1). The presence of
gata3 protein at all time points was confirmed both by
immunocytochemistry and by immunoblotting. Signal detection
from the array data through the first 7 days was variable. MAS v.5
did not preserve the RT-PCR profile for gata3 (Fig. 1A). The RMA
profile oscillated during the first week but the peak expression level
was less than 2-fold higher than that at the start and not
significantly better than the biological noise (Fig. 1B). gMOS did
not detect a signal for the probe set at selected time points, which
made the expression profile very irregular through the first 7 days,
although it represented the peak as significant (Fig. 1C). mgMOS
took account of the correlation between Perfect Match (PM) and
MisMatched (MM) values on the arrays and provided a more
accurate estimate than gMOS of low levels of expression as well as
revealing the overall profile (Fig. 1D). The difference in the
estimated level of gene expression between the first time points and
the peak expression was about 5-fold which is substantially higher
than the background noise. For each time point for both gMOS
and mgMOS we plotted the variances evaluated by rejection
sampling [33] from the posterior distribution of the parameters
defining the gene expression signals. With mgMOS the variances
were larger where the signal was low, a measure of uncertainty
that was an important component of the subsequent clustering
process.
To further compare gMOS with mgMOS we plotted the
contours of the likelihood functions for the PM and MM values of
the whole dataset for days 2 and 4 and found that mgMOS fitted
the data better than gMOS (Fig. 2). The more accurate
performance of mgMOS was confirmed by calculation of Akaike’s
Information Criterion (AIC) [34] and the Bayesian Information
Criterion (BIC) [35]. In this kind of data where the number of
observations is smaller than 25, AIC has a tendency to overfit. To
cover this issue, we also calculated the values of the bias correction
of AIC (AICC) [36]. The results for all three information criteria
(Table 1) showed that mgMOS was consistently better than gMOS
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across the full temporal profile. Thus mgMOS provided a better
model for this type of data than MASv.5, RMA or gMOS and we
used it in the next stage to analyse temporal expression profiles.
Analysis and hierarchical clustering of temporal
expression profiles
Gene expression signals and associated uncertainties were
extracted directly from the raw image (.CEL) files. Genes that
shared similar expression profiles with gata3 were grouped together
by hierarchical clustering [37]. The precision measures obtained
from mgMOS were used to smooth off noisy points and the
similarity measures were calculated with respect to the differences
between time points [38]. This was done to reduce fluctuation in
the expression profile and thereby generate a more robust
correlation measure. The approach is novel for gene expression
data but is often used in time series analysis where a high rate of
fluctuation in the data is expected. Both the difference approach in
performing hierarchical clustering and the accuracy with which
mgMOS estimated gene expression levels allowed us to generate
robust, objective lists of genes clustered to gata3.
Temporal expression profiles were correlated with that of gata3
in each cell line and ranked according to their Spearman
correlation value. All genes with a correlation coefficient greater
than 0.80 were then selected (Tables S1–S3). To gain a
preliminary functional insight into our gata3 clusters we analysed
the representation of different gene families with the PANTHER
(Protein ANalysis THrough Evolutionary Relationships: http://
www.pantherdb.org) system [39]. We included all genes that were
clustered to gata3 with a correlation coefficient of at least 0.80 in all
cell lines. In terms of Biological Processes significant representation
(p,0.05) was found for cell proliferation and differentiation,
apoptosis and intracellular signalling (Table 2). We then
conducted a PANTHER Pathway analysis [40] to identify gene
families associated with specific signalling pathways. Apoptosis,
tyrosine kinase receptors (including FGF, PDGF and EGF) and
integrin signalling were all represented in the top 10 pathways,
consistent with previous studies on gata3 [18,26].
Core processes regulated by gata3
We assumed that the data from individual cell types would
include genes that were directly and indirectly linked to gata3
function in those cells. To identify genes that were more
fundamentally linked to systems regulated by gata3 we identified
those that were common to all clusters and that shared correlation
coefficients of .0.80. In this way we objectively established an
unbiased list of 26 genes that correlated most closely with gata3 in
all of the datasets (Table 3). Ten of these genes were associated
with insulin-like growth factor (IGF) signalling, including Akt2,
Igfbp7, Igfbpl1, MAP4K3 and Ywhaz (see discussion).
To validate this list and our estimates of gene expression level
from the microarrays we assessed expression of 24 of the 26 genes
in the final cluster to gata3 by real time RT-PCR in the cell line
VOT-E36 after 2 days of differentiation in vitro (Table 4). To
strengthen this validation we included an additional 37 genes from
Figure 1. Temporal profiles for gata3 in OC-1 cells calculated with four different models.We compared the expression profiles derived for
gata3 from each model (solid lines) with the Taqman qRT-PCR profile (dotted line). To compare the data both the qRT-PCR values and the expression
levels were standardised by subtracting the respective means and dividing by their standard errors. For gMOS and mgMOS we have plotted the
variances evaluated for each time point by rejection sampling from the posterior distribution of the shape parameter a. A) MAS v.5, B) RMA, C) gMOS
and D) mgMOS.
doi:10.1371/journal.pone.0007144.g001
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outside the final cluster and for which effective probes were
available. Given the association with PKB/Akt and IGF-signalling
we selected the additional genes from these signalling pathways
(Supplementary Table S4). There was a strong inverse correlation
between the expression levels estimated by mgMOS and the DCT
value from the RT-PCR (Fig. 3; n = 61, R2= 0.7, p,0.0001). The
range of values for absolute expression level was surprisingly close
in terms of ‘fold change’ for the two methods. For example, ywhaz
was expressed at a relatively high level with a log2 value of 10.0
and a DCT of 14.2, whilst igfbp7 had a log2 value of 3.0 and a DCT
Figure 2. Contour plots to compare the performance of MASv5, RMA, gMOS and mgMOS. Contours of the likelihood functions of gMOS
and mgMOS for the Perfect Match and MisMatch values of the gata3 probe set for the cell line OC-1 at day 2 and day 4. To better assess the models
we used Akaike’s Information Criterion (AIC), the Bayesian Information Criterion (BIC) and the bias correction of AIC (AICC – See Table 1).
doi:10.1371/journal.pone.0007144.g002
Table 1. Evaluation of AIC, AICC and BIC using OC-1 dataset.
Time Course gMOS AICC mgMOS AICC gMOS AIC mgMOS AIC gMOS BIC mgMOS BIC
day 0 708.88 655.72 706.88 653.05 709.87 657.03
day 1 706.24 655.32 704.24 652.65 707.23 656.63
day 2 716.75 666.89 714.75 664.22 717.73 668.2
day 3 737.72 694.48 735.72 691.81 738.71 695.8
day 4 713.97 671.84 711.97 669.17 714.96 673.15
day 5 706.34 658.15 704.34 655.48 707.33 659.47
day 6 705.72 667.21 703.72 664.54 706.71 668.52
day 7 693.88 647.17 691.88 644.5 694.87 648.48
day 8 717.85 681.03 715.85 678.36 718.83 682.34
day 9 717.83 679.75 715.83 677.09 718.81 681.07
day 11 675.76 629.53 673.76 626.86 676.75 630.85
day 14 741.91 696.65 739.91 693.98 742.9 697.96
Results for model selection by the Akaike’s Information Criterion (AIC), the corrected Akaike’s Information Criterion (AICC) and Bayesian Information Criterion (BIC) using
the Gata-3 temporal profile data in OC-1. The bold data is associated with the better model.
doi:10.1371/journal.pone.0007144.t001
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of 23.0. These values represent a correlation across differences
(fold changes) over the detection level of 27–29. This correlation
provides strong experimental support for the application of
mgMOS for estimating gene expression level from microarray
data.
The next task was to test the functional relationships between
gata3, the genes listed in the final cluster and those associated
with igf signaling. It was not possible to achieve a stable
inactivation of gata3 in cell populations through equivalent
temporal profiles. However, we were able to knock down gata3
with siRNA at one time-point in a single cell line (Fig. S1) and to
screen for changes in the same list of 61 genes analysed in the
previous experiment. In terms of the original gata3 cluster, 7 of
the 26 genes were not detected by RT-PCR, 7 had lower
expression levels in siRNA-treated cells, 2 had higher expression
levels and 10 remained unchanged (Table 4). There was no
measurable change in expression of the igf1 receptor (igf1r) but
there was a measurable down-regulation of genes in the IGF-
signalling pathway, notably igf1, igf2, igfbp2, igfbp3, igf2bp3 and
irs1. Pik3cg was up-regulated. Considering the limitations of
focussing on a single time-point and the fact that shared temporal
expression profiles do not necessarily correlate with direct
regulation, the observed changes provide clear evidence that
gata3 is functionally linked to IGF-signaling. Because PKB/Akt
Table 2. Biological process analysis of genes clustered to
gata3 in silico.
Rank Biological Process (from a total of 241 listed)
1 Cell proliferation and differentiation
2 Apoptosis
3 Protein metabolism and modification
4 Nucleoside, nucleotide and nucleic acid metabolism
5 Cell cycle
6 Cell cycle control
7 Intracellular signalling cascade
8 Sensory perception
9 Developmental processes
10 Transport
All genes clustered to gata3 with a minimum correlation coefficient of 0.80
were analysed through the Panther system to compare their frequency of
representation with that for the whole genome. The top ten cellular processes
listed here, from a total of 241, were derived from the combined ranks from the
three datasets.
doi:10.1371/journal.pone.0007144.t002
Table 3. Genes clustered to gata3 in all cell lines and hybridizations.
Genes clustered to gata3 in all cell lines and hybridisations Gene Description
Akt2 thymoma viral proto-oncogene 2
Atp1a2 ATPase, Na+/K+ transporting, alpha 2 polypeptide
Clcn7 chloride channel 7
Cry1 cryptochrome 1 (photolyase-like)
Cryl1 crystallin, lamda 1
Cyp2b10 cytochrome P450, family 2, subfamily b, polypeptide 10
Dusp1 dual specificity phosphatase 1
Gas2 growth arrest specific 2
Gata3 GATA binding protein 3
Igfbp7 insulin-like growth factor binding protein 7
Igfbpl1 insulin-like growth factor binding protein-like 1
Itga6 integrin alpha 6
Map4k3 mitogen-activated protein kinase kinase kinase kinase 3
Mapk8ip3 mitogen-activated protein kinase 8 interacting protein 3
Mapt microtubule-associated protein tau
Mlf2 myeloid leukemia factor 2
Mmp11 matrix metalloproteinase 11
Pitpn phosphatidylinositol transfer protein
Pxmp3 peroxisomal membrane protein 3
Scn3a sodium channel, voltage-gated, type III, alpha polypeptide
Serpind1 serine (or cysteine) proteinase inhibitor, clade D, member 1
Slc11a2 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2
Slc34a1 solute carrier family 34 (sodium phosphate), member 1
Sparcl1 SPARC-like 1 (mast9, hevin)
Tm4sf7 transmembrane 4 superfamily member 7 - tetraspanin 4
Ywhaz tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
List of genes common to all cell lines that clustered to gata3 with a minimum correlation coefficient of 0.80.
doi:10.1371/journal.pone.0007144.t003
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was listed in the final cluster to gata3 and it is the crucial hub
signalling kinase in the IGF pathway [41] we chose to explore its
functional links to gata3 in vitro and in vivo.
PKB/Akt
PKBb/Akt2 is a serine-threonine kinase and the second of 3
mammalian isoforms, all of which were represented on the arrays.
These kinases act as signalling hubs in a wide range of cellular functions
from proliferation to growth, survival, apoptosis and differentiation
[29]. They generally act downstream of receptor tyrosine kinases and it
has been estimated that they potentially have up to 9000 downstream
targets [42]. In the context of our original hypothesis that gata3
regulates a core signalling pathway and in the light of our Panther
system analysis, the potential link between gata3 and PKBb/Akt2 was
critical. Any influence of gata3 on the IGF pathway upstream of PKB/
Akt should be reflected in the activation of these kinases.
Table 4. qRT-PCR analysis of gene expression in VOT-E36 two days after differentiation in vitro.
Gene
Expression level in array for E36
at day 2 of differentiation in vitro
DCT - Taqman expression
level for control
DDCT - Change in expression
after knock down of gata3
Summary
comment
Akt2 9.1 16.6 20.260.04 No change
Atp1a2 Not detected Not detected Not detected Not detected
Cdkn1b* 7.5 16.1 20.660.06 Down
Clcn7 8.6 17.3 0.160.09 No change
Cry1 7.0 20.7 20.160.11 No change
Cryl1 5.3 19.8 20.560.05 Down
Cyp2b10 1.9 Not detected Not detected Not detected
Dusp1 8.6 18.4 0.260.09 No change
Gas2 4.1 19.7 20.460.09 No change
Gata3 9.6 14.7 20.860.04 Down
Igfbp7 3.0 23.0 0.560.14 Up
Igfbpl1 1.4 Not detected Not detected Not detected
Itga6 8.0 15.1 0.560.03 Up
Map4k3 No probe No probe No probe No probe
Mapk8ip3 6.6 20.4 0.160.03 No change
Mapt 4.6 20.7 20.260.11 No change
Mlf2 8.8 17.4 0.360.05 No change
Mmp11 8.3 19.8 20.460.06 No change
Pitpn 6.3 18.8 20.760.07 Down
Pxmp3 8.1 21.2 20.660.15 Down
Scn3a Not detected Not detected Not detected Not detected
Serpind1 4.4 24.9 22.960.06 Down
Slc11a2 7.0 19.4 0.360.08 No change
Slc34a1 3.9 Not detected Not detected Not detected
Sparcl1 0.9 20.3 20.560.01 Down
Tm4sf7 No probe No probe No probe No probe
Ywhaz 10.0 14.2 20.560.01 Down
Igf1 8.1 19.0 20.760.02 Down
Igf1r 9.8 14.6 20.160.08 No change
Igf2 12.2 12.5 20.760.03 Down
Igfbp2 10.3 13.0 21.560.07 Down
Igfbp3 7.8 15.7 21.060.05 Down
Igf2bp3 Not detected 22.1 21.660.06 Down
Irs1 2.7 20.7 20.760.01 Down
Pik3cg Not detected 31.0 2.460.50 Up
Foxo1 Not detected 13.0 20.560.03 Down
The table includes the 26 genes from the final cluster to gata3 and 9 from the IGF and Akt/PI3K signaling pathways for which we detected a significant change in
expression following knock-down of gata3. *Cdkn1b (p27kip1) was not in the final cluster to gata3 but is included here as a potential target of PKB/Akt. The correlation
between expression levels from the arrays (column 2) and from Taqman analysis (column 3) for all 61 genes assessed by qPCR was highly significant and is shown in
figure 3. Following knock-down of gata3, the expression levels of 9 of the 26 genes within the original gata3 cluster changed significantly (7 down, 2 up, 10 unchanged,
7 undetected/no probe). Significant changes in expression were also observed for 8 genes outside the gata3 cluster but in the IGF signaling pathway. These included igf
and igf2 but not igf1r. The threshold for change was set at a DDCT value of 0.5 following subtraction of the variance.
doi:10.1371/journal.pone.0007144.t004
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In the array data the profiles for PKBb/Akt2 were highly
correlated with gata3 with respect both to shape and to absolute
expression level. Those for PKBa/Akt1 did not appear in the final
list for all cell lines although the correlation in VOT-E36 without
serum was ranked very close to that for PKBb/Akt2. The signal
profile for gata3 in OC-1 showed an initial log2 expression value
of about 6 at day 0, which increased by about 4-fold to a value of
10 at days 8–9 (Fig. 4A). There was then a 2-fold decrease by
days 11 and 14. The equivalent profile for PKBb/Akt2 shared a
similar absolute expression level and with the exception of the
transition from day 0 to day 1, the fluctuations between
successive time points of the temporal profile shared a similar
pattern (Fig. 4A). The profile for PKBa/Akt1 did not correlate as
well with that for gata3 until day 6 when they appeared to con-
verge (Fig. 4B).
In VOT-E36 cultured in defined media the expression level for
gata3 was higher with a log2 value of 8–10 (Fig. 4C). The signal
increased by 2–3-fold after 2 days of differentiation and then
decreased slightly to 14 days. These expression levels were
substantially higher than those obtained from the same cell line
cultured with 10% fetal calf serum. However, the relative levels of
expression between the 2 cell lines reflected those in the
equivalent, native epithelial cells during normal development
and were consistent with the high levels of gata3 protein in the
ventral otic epithelium from E11–E18. The expression levels for
PKBb/Akt2 were also higher in VOT-E36 than in OC-1 and the
temporal profile was similar to that for gata3 (Fig. 4C). The profile
for PKBa/Akt1 was also similar to that for gata3. In VOT-N33
cultured with serum gata3 increased dramatically from 0–14 days,
coinciding with a similar increase in PKBb/Akt2 (log2 = 2.1 to 8.0).
This increase was consistent with results from immunohistochem-
istry on the cell line in vitro [43] and on sections of native cochlear
neuroblasts in vivo [15].
The close correlation between gata3 and PKBb/Akt2 was
represented for all cell lines independently of the temporal profiles
by plotting the expression levels of the 2 genes for all 22 array
hybridisations (Fig. 4D). The correlation was highly significant
(R2 = 0.739, p,0.001). The gene expression data thus indicated a
positive correlation between gata3 and PKBb/Akt2 across a 7-fold
range of expression level and a lower but potentially significant
correlation with PKBa/Akt1. Note that the correlation implies that
in the absence of gata3 there is significant expression of PKBb/Akt2.
PKBb/Akt2 is known to have a wider expression pattern than gata3
and the observed correlation does not mean that it is solely or
directly regulated by gata3.
Effects of knocking down gata3 on PKB/Akt in vitro
Immunofluorescence and immunoblotting revealed that gata3,
PKBa/Akt1 and PKBb/Akt2 were present in all of the cell lines.
We tested the effects of knocking down gata3 on PKBa/Akt1 and
PKBb/Akt2 by RNAi in the VOT-E36 cell line after 2 days of
differentiation in vitro. Immunofluorescence labelling in both
VOT-E36 and VOT-N33 cells showed similar results. Gata3 and
PKBb/Akt2 were co-localised in the nuclei of VOT-N33 cells
(Fig. 5A–B) and the immunolabel for both was decreased when
gata3 was knocked down (Fig. 5C–D). In contrast, there was a
striking increase in the cytoplasmic label for PKBa/Akt1, which
not only appeared to be up-regulated but also translocated from
the nuclei (Fig. 5E–F). Immunoblotting revealed that lower levels
of gata3 were associated with a small, reproducible decrease in
PKBb/Akt2 but in the same samples the levels for PKBa/Akt1
increased dramatically (Fig. 5G). This reciprocal change implied
Figure 3. Correlation between gene expression levels calculated using mgMOS and those measured by Taqman RT-PCR. The
correlation coefficient for the 61 genes represented here was significant (R2 = 0.684, p,0.0001), as was that for the 24 genes in the final cluster to
gata3 (R2 = 0.761, p,0.001). The relationship holds over a wide range of log2 values of gene expression from 0–12. The slope is the same for all genes
(solid line for all points) and for those in the final cluster to gata3 (dotted line for filled symbols only). The data show that mgMOS provides an
accurate measure of gene expression for genes expressed at both high and low levels.
doi:10.1371/journal.pone.0007144.g003
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that both isoforms of PKB/Akt can be influenced by gata3 but that
their overall levels, and by inference the levels of PKB/Akt
activation, increase when gata3 is down-regulated.
Expression of gata3, PKBb/Akt2 and PKBa/Akt1 in the
inner ear
If there is a relationship between gata3 and PKBb/Akt2 in vivo
then, despite the wider expression pattern of the latter, the two
proteins should be co-expressed in sensory epithelia and spiral
ganglion neurons during periods of high gata3 expression. In sections
of the cochlea cut from normal mouse embryos at embryonic day
E16.5, PKBb/Akt2 was clearly expressed in the greater and lesser
epithelial ridges as well as in the spiral ganglion (Fig. 6A). This
labelling pattern overlapped that of gata3 at the same stage [17]. The
antibody to gata3 was technically difficult to use because it was
extremely sensitive to tissue fixation. However, double-labelling with
antibodies to PKBb/Akt2 did reveal co-expression in selected cells
(Fig. 6B–H). In cells expressing high levels of gata3 the label for
PKBb/Akt2 appeared to be co-localised in the nuclei. The overall
label for PKBb/Akt2 was weaker in heterozygous gata3 null mice
(Fig. 6I–J) as was the label for gata3 (Fig. S2). More interestingly, the
level of PKBb/Akt2 in adjacent osteoblasts, which do not express
gata3 but depend on PKBb/Akt2 during differentiation [44], was
unchanged in heterozygous gata3 null mice (Fig. S2). In heterozy-
gous null mice colocalisation of gata3 and PKBb/Akt2 was still
evident in the cell nuclei but at lower levels (Fig. S3).
The cochlear expression pattern for PKBa/Akt1 did not correlate
so well with gata3 (data not shown) and included many cells in the
surrounding mesenchyme and connective tissue. Thus the immuno-
Figure 4. Expression profiles for gata3 and PKB/Akt over a period of 14 days in vitro. OC-1 was cultured with serum and in the data
represented here VOT-E36 was cultured in defined media. Cells were transferred to differentiating conditions at 39uC on day 0. All expression levels
were plotted as log2 values in which each unit increase was equivalent to a 2-fold change. A – Expression of gata3 and PKBb/Akt2 plotted against days
of differentiation in OC-1 with serum. The shapes of the temporal profiles for the 2 genes were closely related after day 2. B - Expression of gata3 and
PKBa/Akt1 plotted against days of differentiation in OC-1 with serum. C – Expression levels for gata3, PKBb/Akt2, PKBa/Akt1 and p27kip1 plotted against
time for VOT-E36 in defined culture medium. D – Expression of gata3 plotted against PKBb/Akt2 for all hybridizations, including data for VOT-N33 and
VOT-E36 with serum. Each point represents a separate array, including 12 from OC-1, 6 from VOT-E36 in defined media, 2 from VOT-E36 in serum and
2 from VOT-N33 in serum. The correlation coefficient R2 was 0.739 (p,0.001).
doi:10.1371/journal.pone.0007144.g004
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fluorescence labelling in the native tissue correlated with the array
analysis in the sense that there was a closer spatial relationship
between gata3 and PKBb/Akt2 than between gata3 and PKBa/Akt1.
Activated PKB/Akt in heterozygous gata3 null mice
PKBb/Akt2 was expressed in both heterozygous and homozy-
gous gata3 null mice. Expression in the latter is not surprising
because PKBb/Akt2 is not under the sole regulation of gata3. The
otocyst in null mice remains cystic and it is not possible to identify
the relevant cell types. Thus we were unable to derive meaningful
information by analysing null animals. However, given that knock
down of gata3 led to only a small down-regulation of PKBb/Akt2 but
relatively large upregulation of PKBa/Akt1, as well as movement of
PKBa/Akt1 to the cytoplasm of many cells, we predicted that
overall levels of activated PKB/Akt should increase. This was
reflected in gata3 heterozygous null mice. To study this relationship
we used antibodies to phosphorylated PKB/Akt although they do
not distinguish the different PKB/Akt isoforms. For co-localisation
with gata3 we labelled heterozygous gata3 null mice in which one
gata3 allele was replaced by a tauLacZ reporter gene. The lacZ
expression pattern was correlated with high levels of activated PKB/
Akt in all tissues and in all regions of the inner ear from E10.5 to
E18.5 (Fig. 7). This relationship was also observed in the eye and the
central nervous system. The data supports the previous evidence for
a functional relationship between gata3 and PKB/Akt-signalling in
epithelial, neuronal and mesenchymal tissues.
Gata3, PKB/Akt and p27kip1
Gata3 has been linked to regulation of cell proliferation and
survival [24] and p27kip1 (cdkn1b) is an important regulator of the
cell cycle in cochlear sensory epithelial cells [45,46] and sensory
neurons [47]. p27kip1 is a known target of activated PKB/Akt,
which can down-regulate its expression via FOXO transcription
factors, inhibit its nuclear localisation and enhance its cytoplasmic
degradation [29]. For these reasons we predicted that down-
regulation of gata3 would lead to down-regulation of p27kip1. This
prediction is relevant for the differentiation of hair cells which
down-regulate both genes shortly after specification [17,46].
When gata3 was knocked down with antisense oligonucleotides,
p27kip1 was down-regulated (Fig. 8A) and its expression subsequently
recovered as gata3 levels recovered. Furthermore, nuclear labelling
for p27kip1 was low and often distributed to the cytoplasm in cells
transfected with a dominant negative form of gata3 (Fig. 8B–E).
Finally, the expression of p27kip1 decreased after cells were treated
with RNAi for gata3 (Table 4: DDCT=20.660.06 for cdkn1b).
Discussion
This work shows that unbiased, statistical analysis of temporal
gene expression profiles from appropriate cell lines can reveal
Figure 5. Immunofluorescence and immunoblotting for PKBb/
Akt2 and PKBa/Akt1 in VOT-N33 cultured with and without
gata3 siRNA. A–B – In untreated cells both gata3 and PKBb/Akt2 were
expressed in the cytoplasm and more obviously in the nuclei. C–D –
Treatment with gata3 siRNA caused a loss of label for both gata3 and
PKBb/Akt2. E–F – In untreated cells PKBa/Akt1 was localized primarily to
the nuclei but with siRNA to gata3 the label was much higher and
localized to the cytoplasm. Scale bar = 100 mm. G - Immunoblots for
PKB/Akt in VOT-E36 after treatment with siRNA for gata3. The level of
PKBa/Akt1 increased in the absence of gata3 whereas that for PKBb/
Akt2 decreased slightly relative to levels of tubulin. In the presence of
siRNA gata3 was substantially but not completely knocked down
(Fig. S1). Quantification of 6 different blots from 4 separate experiments
revealed consistent evidence for the changes shown in A. (PKBa/Akt1
p,0.05; PKBb/Akt2 p,0.02).
doi:10.1371/journal.pone.0007144.g005
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novel insights into the function of regulatory genes during
development. The high correlation between the signals derived
from the microarrays and the Taqman RT-PCR shows that
mgMOS is an effective probabilistic tool for analysis of the array
hybridization signals and that it provides accurate estimates of
gene expression level relative to equivalent data from quantitative
RT-PCR. The analysis improved the detection of genes expressed
at low levels and provided a measure of uncertainty for the
expression level of each gene that was critical for ranking the
correlations between temporal profiles. gMOS was developed to
analyse the datasets presented in this paper and is now recognized
as an extremely effective tool [32]. The results reinforce the value
of the data analysis because they reveal a previously unknown
functional association between gata3 and IGF-signalling, partic-
ularly via the hub serine/threonine kinase PKB/Akt.
Association between gata3 and IGF-signalling
The top biological processes associated with genes clustered to
gata3 with a correlation coefficient of at least 0.80, including cell
proliferation and differentiation, apoptosis, cell cycle and intra-
cellular signalling, correlated well with those identified in a dataset
based on differential gene expression profiles in hair follicles from
wild type and conditional gata3 null mice [26]. They are also
consistent with the function of IGF-signalling, which is known to
control cell survival, growth, proliferation and differentiation in
both the auditory sensory epithelium and the spiral ganglion
[48,49,50]. In terms of signalling pathways there was a high
representation of genes associated with apoptosis and with several
tyrosine kinase receptors. The link to fgf-signalling was relevant
since gata3 regulates the expression of fgf10 in the otic placode
[18] and mice lacking either fgf10 or gata3 have a much smaller
otic vesicle [14,19], which is associated with a decrease in cell
proliferation [19]. Fgf10 was represented on the arrays and was
expressed in the cell lines as expected from the expression patterns
from in situ hybridisation at the equivalent stage of development
[18]. However, there was no obvious correlation with gata3 in
terms of the temporal expression profiles. Interestingly, the gata3
clusters for the two epithelial cell lines included fgfr2, which
encodes the receptor for fgf10.
The level of activity of PKB/Akt is critical during development
to mediate IGF-signalling and the balance between cell prolifer-
ation, survival and growth [29,41,51]. However, many other genes
listed in our final cluster to gata3 are associated with IGF-
signalling. The IGF-binding proteins Igfbp7 and Igfbpl1 interact
directly with IGF, the former being widely expressed and binding
IGFs specifically with relatively low affinity [52]. Ywhaz, also
known as 14.3.3z, is a member of a family of proteins that mediate
signal transduction by binding phosphoserine-containing proteins.
It binds insulin receptor substrate 1 (irs1), thus influencing the
sensitivity to insulin/IGF-signalling, but it also binds PKB/Akt
directly [53] and can regulate the nuclear localisation of the cyclin-
dependent kinase inhibitor p27kip1 [54]. Irs1 appeared in the
cluster to gata3 in OC-1 with a correlation of 0.85. The dual
specificity phosphatase Dusp1 is a protein tyrosine phosphatase
with specificities for tyrosine and threonine and the ability to
inactivate mitogen-activated protein kinase [55]. It is linked to cell
proliferation and cell cycle control but also mediates apoptosis in
rat pituitary tumour cells in response to thyroid hormone [56].
The phosphatidylinositol transfer protein, Pitpn, regulates intra-
cellular transfer of phospholipids and the activity of phosphatidy-
linositol signalling pathways [57,58].
The gene encoding the sodium/potassium ATPase subunit
ATP1a2 also appeared in the final cluster to gata3. In vascular
smooth muscle cells IGF-1 stimulates Na,K-ATPase via activation
of PKB/Akt [59]. Ouabain inhibits Na,K-ATPases and can
protect cultured kidney cells from apoptosis via activation of PKB/
Akt [60]. Na,K-ATPases have a fundamental role in cellular
Figure 6. Expression of gata3 and PKBb/Akt2 in E16.5 mouse
cochlea. A – Immunofluorescence image of a cryosection through an
unfixed, wild-type cochlea at E16.5 labeled with antibodies to PKBb/
Akt2. The spiral cochlear duct (*) was sectioned in 3 places. GER/LER –
Greater/Lesser epithelial ridge, SG – Spiral ganglion. B,C,D,E -
Immunofluorescence images of a longitudinal section along the organ
of Corti. Where nuclear labeling for gata3 was high the label for PKBb/
Akt2 was also nuclear (arrows). Note that the top layer of cell nuclei
labeled for DAPI (E) was very weakly labeled for gata3. F,G,H –
Immunofluorescence images of a transverse section through the organ
of Corti. Nuclei that labeled strongly for gata3 also labeled for PKBb/
Akt2 (arrows). Hair cell nuclei (cells indicated by arrowheads) were
weakly labeled for gata3 and correspond to the top layer of cell nuclei
in panel E. I,J - Immunofluorescence images of a transverse section
through the organ of Corti from a heterozygous gata3 null mouse. The
images were prepared in parallel with those shown in panels F-H and
indicate a lower level of label for PKBb/Akt2. Scale bars = 100 mm.
doi:10.1371/journal.pone.0007144.g006
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homeostasis and may play a key role in neuronal cell death and
neurodegeneration [61,62,63], thus their reduced function in gata3
heterozygous null mice could account for the premature
degeneration of the sensory epithelium. ATP1a2 null mice suffer
progressive hearing loss with minimal change in cochlear
morphology [64]. Interestingly, these mice also have higher
intracellular levels of chloride ions in their neurons mediated by
malfunction of cation-chloride transporters [65] and hearing loss
can be rescued by crossing the animals with those lacking the
sodium/potassium/chloride transporter NKCC1 (SLC12a2) [64].
The presence of the intracellular chloride channel Clcn7 in the
gata3 cluster is worth noting in this context.
Integrin a6 is dynamically regulated during neuroblast
migration and epithelial differentiation in regions of the otocyst
that express gata3 [66]. It’s up-regulation in breast cancer cells
leads to activation of PKB/Akt [67]. In prostate cancer cells IGF1
regulates expression of avb3 integrin via activation of PKB/Akt
[68]. Thus the presence of Integrin a6 and Tm4sf7 (Tetraspanin
4), which forms complexes with Integrin a6 [69], may also be
linked to IGF-signalling.
Finally, gata3 and PKB/Akt bind directly to smad3 [70,71] and
may thus modulate interactions between IGF and TGFb-
signalling pathways. The 3-phosphoinositide-dependent kinase
PDK1, which phosphorylates PKB/Akt, also binds smad3 and is
up-regulated with increased levels of IGF1 but down-regulated
with higher levels of TGFb [72]. Gata3 may thus regulate cell
survival by priming the balance between these two pathways.
Apoptotic pathways
Several proteins encoded by genes in the gata3 cluster apart
from PKB/Akt are associated with apoptosis. The Cyp2 family of
cytochrome p450 epoxygenases generate biologically active
eicosanoids that act as second messengers in numerous signalling
pathways, including those mediated by PKB/Akt, to regulate
various processes including apoptosis [73]. Cryl1 encodes a
lambda-crystallin found in lens cells and that is highly expressed
in liver and kidney [74]. Alpha-and beta-crystallins are known
anti-apoptotic regulators in lens cells where their effects are
mediated by the PKB/Akt and RAF/MEK/ERK pathways,
respectively [75]. Mu-crystallin (Crym) is associated with gata3 in
hair follicles [26,76] and is linked to human deafness [77,78].
Growth arrest specific protein Gas2 is a substrate of caspase-3 that
sensitises cells to apoptosis in a p53-dependent manner [79].
MAP4K3 and MAPK8IP3 are involved in the JNK pathway, the
activation of which facilitates apoptosis. In Drosophila, MAP4K3
is required for maximal activation of S6 kinase [80], which is part
of a negative feedback to insulin/IGF receptor signalling [81,82].
The matrix metalloproteinase Mmp11 mediates cell survival in
epithelial cells via activation of PKB/Akt [83].
Gata3 is functionally linked to activation of PKB/Akt
The diverse but highly conserved function of gata3 [12] suggests
that it regulates core elements of cell behaviour. Our results
demonstrate a clear functional link to PKB/Akt although the
association is complex. Although the gene array data indicated a
Figure 7. Correlation between expression of gata3 in heterozygous null mice and immunolabelling for phosphorylated PKB/Akt. A -
A section through the back of the head of a mouse at E11.5 showing regions expressing tau-LacZ in the hindbrain and in the ear. Scale bar = 500 mm.
B – The same section as A labeled with antibodies to phosphorylated PKB/Akt. Note the similar labeling patterns in A and B. C,D,E – A higher
magnification of a transverse section through the mid region of the inner ear showing tissue nuclei (Dapi), tau-LacZ and immunolabel for
phosphorylated PKB/Akt, respectively. F,G,H – As C-E but for a section through the cochlear duct. I,J,K – As C–E but for a section through the eye and
optic nerve (top left of each panel).
doi:10.1371/journal.pone.0007144.g007
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high correlation between the expression levels of PKBb/Akt2 and
gata3 we detected little change in the expression of PKBb/Akt2
following knock-down of gata3. However, PKBb/Akt2 was
translocated from the nucleus to the cytoplasm with some evidence
for down-regulation of the protein. An exclusive transcriptional
link is unlikely because although the expression patterns for the
two proteins were similar throughout the ear they were not
identical and PKBb/Akt2 was clearly expressed in groups of cells
that lacked gata3. Nevertheless, nuclear localisation in vivo
coincided with cells expressing high levels of gata3, consistent
with the in vitro data. We conclude that the association was
detected in the temporal profiles of gene expression because gata3
and PKBb/Akt2 are simultaneously up-regulated and that they
interact as proteins in a coherent functional pathway. The
experimental approach was designed to identify intracellular
processes associated with gata3 at physiological levels of expression
rather than to identify direct transcriptional targets. Information
derived from temporal profiles of gene expression cannot readily
be compared with results from a knock-down of gata3 in a single
cell line at a specific time-point. The value of clustering temporal
profiles depends on the assumption that the expression levels of
functionally related genes change synchronously with time and
that they reflect coherent cellular behaviours. In this context the
data can potentially include transcriptional and protein-protein
relationships.
The correlation between the expression of PKBa/Akt1 and gata3
was not as high as that for PKBb/Akt2 across all cell lines but was
significant in VOT-E36 and from day 4 in OC-1 (Fig. 4).
However, the effect of knocking down gata3 at day 2 of
differentiation in VOT-E36 was dramatic in terms of the up-
regulation of PKBa/Akt1 protein and its translocation from the
nucleus. The results show not only that gata3 regulates PKB/Akt
but also that it has differential effects on PKBa/Akt1 and PKBb/
Akt2. Whilst we cannot conclude direct transcriptional control by
gata3, when it was knocked down we observed changes in
expression of several genes in the IGF-signalling pathway (Table 4),
suggesting that there may be several ways in which changes in the
expression of gata3 could influence the activity of PKB/Akt.
Gata3, PKB/Akt and IGF-signalling
Evidence for links between gata3, IGF-signalling and PKB/Akt
in vivo come from studies on null mice. Gata3 is involved in the
Figure 8. Regulation of p27kip1 by gata3 in the cell line VOT-N33. A – Antisense oligonucleotides used to knock down expression of gata3 led
to simultaneous loss of p27kip1 protein. B–D – These images are from the same group of cells. dnGata3 (green label in B) led to cytoplasmic
localisation of p27kip1 (labelled in red) and loss from the nucleus (C,D). E – In cells transfected with dngata3 the levels of p27kip1 protein were
significantly lower (p,0.0001). This result correlated with a decrease in expression of p27kip1 (cdkn1b) following treatment with siRNA to gata3
(Table 4).
doi:10.1371/journal.pone.0007144.g008
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determination of skin cell lineages and when it is conditionally
knocked down in the epidermis and hair follicles the animals suffer
growth defects and dwarfism [26]. Pups are thinner with a
substantial reduction in subcutaneous adipose tissue. This
phenotype is similar to that described for mice lacking both
PKBa/Akt1 and PKBb/Akt2 with respect to dwarfism, impaired
skin development and impeded adipogenesis [41]. It also closely
resembles the phenotype of IGF-receptor null mice [84],
prompting the conclusion that despite being a downstream
effector of multiple growth factor receptors, PKBa/Akt1 and
PKBb/Akt2 are the most critical effectors of IGF signalling during
development [41]. The striking similarities of these phenotypes
reinforce the conclusions that we have drawn from an entirely
objective gene expression analysis and suggest that the method
provides an effective tool with which to explore the function of
gata3 and other regulatory genes.
Materials and Methods
Cell lines and cell culture
Three conditionally immortal cell lines were used for the gene
expression analysis. UB/OC-1 (OC-1) was derived from auditory
sensory epithelial cells at embryonic day E13.5, just prior to hair
cell differentiation [85]. US/VOT-E36 (VOT-E36) was derived
from epithelial cells in the ventral, auditory region of the otocyst at
E10.5 and US/VOT-N33 (VOT-N33) was derived from auditory
neuroblasts delaminating from the ventral otic epithelium at E10.5
[7]. All lines were selected for expression of gata3 protein.
The cells were cultured both in serum and serum free
conditions. In serum VOT-E36, VOT-N33 and OC-1 were
cultured in MEM (Invitrogen-GIBCO, Paisley, UK) and 10% fetal
bovine serum (FBS) (Invitrogen-GIBCO, Paisley, UK) under
immortalising conditions (33uC with c-interferon (Peprotech Ec
Ltd, London UK) and under differentiating conditions (39uC
without c-interferon). In serum free: VOT-N33 cells were cultured
in Neurobasal Medium (NM) (Invitrogen-GIBCO, Paisley, UK)
with 1% L-Glutamine (Invitrogen-GIBCO, Paisley, UK) and
2.5% FBS under immortalizing condition, and 2% B27 supple-
ment (Invitrogen-GIBCO, Paisley, UK) under differentiating
conditions. VOT-E36 cells were cultured in Ultraculture Medium
(Cambrex-BioWhittaker, Europe) with 1% L-Glutamine. Flasks
and dishes were coated with poly-D-lysine (Signa-Aldrich, UK)
and fibronectin (Sigma-Aldrich, UK) was added to the medium
just before plating.
Gene array hybridization
The gene expression profiles were based on Affymetrix
GeneChipH Mu11k (chip A and B) for the OC-1 cell line and
GeneChipH Mg_U74Av2 arrays for VOT-E36 cell line.
Total RNA was prepared with Qiagen RNeasy mini-kits
according to the manufacturer’s instructions. cRNA was prepared
as described in the Affymetrix GeneChip Expression Analysis
Technical Manual. A comprehensive list of genes present in the
chips and search tools are available at http://www.netaffx.com.
Gata3 null mice
Homozygous and heterozygous gata3 null mice in which the
gata3 alleles were replaced with a taulacZ reporter gene [24] were
used to study co-expression with PKB/Akt and to study the effects
of loss of function of gata3. They were bred from a cross between
heterozygous parents to produce both types for comparison of
pups from the same litter. Animal care and use was in accordance
with the UK Home Office (Animal Procedures) Act 1986.
Sections
C57/BL6 mice were killed by cervical dislocation in accordance
with Home Office guidelines and the required tissue dissected out
at 4uC in PBS. If PFA fixation was required then the tissue was
immersed in 4% PFA in PBS for 2 hours at 4uC. The tissue was
washed 3 times in PBS for 10 minutes per wash and cryoprotected
in a 30% sucrose solution in PBS overnight at 4uC. Once the tissue
had fully absorbed the cryoprotectant it was briefly dabbed dry
and then frozen in Cryo-M-Bed embedding compound (Bright,
UK) using liquid nitrogen cooled isopentane (BDH, Poole,UK).
Embedded tissue blocks were stored long term at 280uC. Tissue
samples were serially sectioned at 12 mm thickness onto gelatin/
chrome-alum subbed slides with a cryostat (Bright,UK). Sectioned
material was then stored at 280uC until required for processing.
Antibodies, immunolabelling & microscopy
Cell culture media was aspirated from culture dishes and the
cells fixed in either 4% Paraformaldehyde (PFA) (Sigma-Aldrich,
UK) in Phosphate Buffered Saline (PBS) (Oxoid, UK) or a 1:1
acetone/methanol mixture depending upon the primary antibody
to be used. 4% PFA in PBS was immediately applied for
10 minutes. Acetone/methanol was applied for 2 minutes, before
being aspirated and the cells allowed to dry for 5 to 10 minutes.
After fixation, blocking solution consisting of 5% Goat Serum
(Sigma-Aldrich, UK) in PBST was applied and allowed to block
for 10 minutes. Blocking solution was removed and primary
antibody in blocking solution applied at the required dilution.
Primary antibodies used were mouse anti-GATA3 at 1:50 (Santa
Cruz Biotech, US), mouse anti-Akt1 at 1:50 (Cell Signaling
Technology, US), rabbit anti-Akt2 at 1:150 (Cell Signaling
Technology,US), rabbit anti Phospho-Akt (Thr308) (Cell Signaling
Technology, Us) at 1:100. Tissue culture dishes were placed into a
humidified chamber and allowed to incubate with primary
antibody for 2 hours. Primary antibody solution was then
aspirated and cells washed 3 times in PBST for 5 minutes each
wash. An FITC or TRITC tagged secondary antibody (Sigma-
Aldrich, UK) raised against the appropriate animal was incubated
with the cells for 1 hour in a blacked out and humidified chamber
at a dilution of 1:200 in blocking solution. Secondary antibody was
aspirated and the cells washed 3 times in PBST for 5 minutes each
wash. If required DAPI (4,6-Diamidino-2-phenylindole) (Sigma-
Aldrich, UK) was added to the final PBST wash at a dilution of
1:500 to allow for nuclear staining. The dishes were then mounted
with Slowfade Gold (Molecular Probes Inc, US) mounting media
and 32 mm glass coverslips (SLS, Scientific Laboratory Supplies,
UK).
Sections were removed from storage at 280uC and allowed to
thaw and air dry before being processed. A DAKO delimiting pen
(DAKO Cytomation, Denmark) was used to form a barrier
around each tissue section. Blocking solution consisting of 5%
Goat Serum (Sigma-Aldrich, UK) in PBST was applied and
allowed to block for 30 minutes. Sections were allowed to incubate
in primary antibody (used at same concentrations as above) at 4uC
over night. Primary antibody solution was then aspirated and cells
washed 3 times in PBST for 5 minutes each wash. An FITC
(Sigma-Aldrich, UK) or Alexa Fluor 568 anti-mouse IgG1(c1)
tagged secondary antibody (Molecular Probes, Invitrogen UK) was
incubated for 1 hour in a blacked out and humidified chamber at a
dilution of 1:200 in blocking solution. Secondary antibody was
aspirated and the sections washed 3 times in PBST for 5 minutes
each wash. After the final PBST/DAPI wash the slides were
mounted with Slowfade Gold mounting media and 22664 mm
glass coverslips (BDH, Poole, UK).
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All visualization of immunohistochemistry was performed using
a Zeiss Axiocam (Zeiss, US) attached to a Leica DMR microscope
(Leica, Germany) connected to a computer running the Axiovision
software (Zeiss, US).
Immunoblotting
Protein extracts were prepared from cells growing at 33uC for
2 days and at 39uC for 1 to 7 days [86]. Cells from 80 cm2 flasks
were lysed on ice adding 100 ml per flask of swelling buffer A
(0.5M HEPES,1M KCl, 1M MgCl2, 1M DTT, 1M PMSF,
Aproptin, Pepstatin A, Leupeptin and phosphatase inhibitors).
Cells were allowed to swell on ice for 10 minutes and then
centrifuged at 4uC at high speed for 3 minutes. Supernatant was
saved for cytosolic proteins and stored at 280uC. The pellet was
washed with 500 ml of buffer A and placed on 500 ml of buffer A
with 47% sucrose and centrifuged at 15 RPM for 10 minutes. The
pellet was than resuspended in 20–100 ml (according to the starting
number of cells) of cold buffer C (20 mM HEPES, 25% glycerol,
420 mM naCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1M PMSF,
Aproptin, Pepstatin A, Leupeptin and phosphatase inhibitors) and
incubated on ice for 10–20 minutes for high-salt extraction. Debris
was removed by centrifugation and the supernatant stored at
280uC. Supernatants were assayed for protein concentration
using the Bradford protein assay method. Samples containing 20–
30 mg of protein were diluted with 46sample buffer and boiled for
2–3 minutes before loading onto 7.5%–10% SDS PAGE gels.
Proteins were transferred to nitrocellulose membranes using a
semi-dry blotting system in 25 mM Tris, 192 mM glycine, 20%
methanol and 0.1% SDS.
Dominant negative gata3
Cells were seeded at a density of 66104 into 35 mm Nunclon
tissue culture dishes (Nunc-Thermo Fisher Scientific, US) in low
serum conditions consisting of Neurobasal media, 2.5% FCS, 1%
gamma interferon and 1% L-glutamine and left to attach at 33uC
for 24 hours. They were then washed with Neurobasal and
transferred into serum free conditions consisting of Neurobasal
media, 2% B27 supplement, 1% L-glutamine. Transfection with
the gata3 KRR dominant negative DNA construct [87] was
undertaken using Fugene6 (Roche, Burges Hill, UK) in accor-
dance with the manufacturer’s protocol. The cells were returned to
33uC for 24 hours to allow transfection to occur and then
transferred to 39uC to allow differentiation to occur for up to
5 days.
Gene silencing with RNAi
Gene silencing was performed using SilencerTM Pre-designed
siRNA for gata3 from Ambion,Inc. (cat # 16704). Two different
siRNA oligos were used (#61810 and #61725). The protocol for
the transfection agent siPORTTM Lipid from Ambion, Inc. (cat #
4504) was optimised for each cell type used. Cells were transfected
both in serum and in serum free conditions when shifted to 39uC.
The transfection protocol suggested by Ambion for a 6-well plate
was used in a 35 mm Petri dish, containing 1.5 ml of media. The
cells were seeded at a density of 6.5–7.06104 in serum free media
and at 6.06104 in serum. The transfection protocol was as follows:
siPort lipid 6 ml (5 ml in serum free condition), 10 ml Opti-MEM
(Invitrogen-GIBCO, Paisley, UK), siRNA 150 nM dissolved in
Opti-MEM. The lipid port was incubated for 40 minutes and then
mixed with siRNA dissolved in Opti-MEM. The complex was left
to incubate for 40 minutes at room temperature before transfec-
tion. The efficiency of the transfection was checked with cy3
labelling of the siRNA using SilencerTM siRNA Labelling Kit
(Ambion Inc. cat # 1632). For transfection of 80 cm2 flasks the
protocol was scaled up to 9 ml of media and cellular density to
66105 proportional to the increased surface of adherence and
optimised to have more than 70% confluence after 24 h in culture.
The knock down of gata3 was tested with immunoperoxidase
labelling, using primary antibody mouse anti-GATA3 at 1:50
(Santa Cruz Biotech, US) and secondary biotinylated mouse
antibody (Vector Laboratories, US) at 1:200. Visualisation was
achieved with a Vectastain ABC kit (Vector Laboratories, US) and
peroxidase substrate kit (Vector VIP). The pixel intensities of 104
cells were measured in a control culture and in a siRNA culture.
The cumulative distributions of the pixel intensities of both control
and knock down cells were calculated. Normal probability plots
and histograms were produced to check the distributions fit.
Although both distributions were comparable the average pixel
intensity in the control cells was 2.2 times higher than the knock
down cells (Fig. S1).
Gata3 phosphorothioate oligonucleotides
Antisense (AS) oligodeoxynucleotides were designed against the
translational start region of GATA3 and consisted of 21-mer
analogues [43]. A complimentary sense (S) sequence was designed
and used as a control. Untreated cells (C) were also used as
controls. The oligodeoxynucleotides were synthesised with a
phosphorothioate backbone to improve resistance to endonucle-
ases. The sequences, manufactured by MWGBiotech UK LTD,
were as follows: GATA3 ‘AS’ DNA; 59-CGC AGT CAC CTC
CAT GTC CTC-39; GATA3 ‘S1’ DNA; 59-GAG GAC ATG
GAG GTG ACT GCG-39; and GATA3 ‘S2’ DNA; 59-CTC CTG
TAC CTC CAC TGA CGC-39. Cells were cultured in 35 mm
dishes or in 75 cm2 flasks in MEM/FCS and transiently
transfected with various concentrations of either GATA3 AS or
sense oligonucleotides mixed with Lipofectamine/Plus Reagent
(Life Technologies, Gaithersburg, US) for up to 72 h at 33 and
39uC. Optimal concentrations were determined and the following
concentrations selected: 16105 cells/35 mm dish, 0.4 mM
GATA3 AS/S, 6 ml Lipofectamine, 6 ml Plus Reagent and
300 ml MEM or 5–86105 cells/75 cm2 flask, 1.5 mM GATA3
AS/S, 20 ml Lipofectamine, 20 ml Plus Reagent and 600 ml MEM.
To assess the effect of the AS, GATA3 treated AS/S cells and non-
treated cells were immunolabeled or immunoblotted with
appropriate primary antibodies. Trypan blue staining was used
to assess cell viability.
TaqMan Low Density Arrays (TLDA)
Harvesting of cells and RNA extraction was carried out with an
RNeasy Mini-Kit (Qiagen) according to the manufacturer’s
instructions. RNA was assessed and quantified spectrometrically
and then stored at 280uC. cDNA was prepared with a High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems)
with 1 mg of total RNA for a final 20 mL reaction volume. After
cooling on ice for 5 min, the cDNA was stored a 220uC. TaqMan
probe and primer sets, including 18S rRNA for use as a reference,
were selected from the Applied Biosystems web site following the
UNIGENE accession number and/or Affymetrix probe set ID for
each target. TaqMan Low Density Arrays (TLDAs) were custom
designed on Applied Biosystems 7900HT 348-well 96a Micro
Fluidic Card platforms. 5 mL of single-stranded cDNA (equivalent
to 250 ng of total RNA) were mixed with 45 mL of nuclease-free
water and 50 mL of TaqMan Gene Expression Master Mix
(Applied Biosystems) and loaded into one sample port. The cards
were centrifuged twice for 1 minute at 330 g and sealed to prevent
well-to-well contamination. They were placed in the Micro Fluidic
Card sample block on an ABI Prism 7900 HT Sequence Detection
System (Applied Biosystems) following the ‘‘standard’’ thermal
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cycling option. Three controls with related RNAi cell cultures were
used in duplicate on three different cards and the data analyzed
together as a relative quantity (RQ) study. Expression values for
target genes were normalized to the concentration of 18S rRNA.
Estimates for gene expression were based on the comparative
threshold cycle (Ct) method. The Ct data for all targets were used to
evaluate the DCt values as (Cttarget - Ct18S rRNA) and then averaged
across replicates. Standard deviation values were also calculated for
each DCt. Subsequently, DDCt values were calculated as DCttarget –
DCtcalibrator. The Control cultures were used as calibrators. The
RQs were calculated as 22 DDCt and the SD for each DDCt was
calculated as (SD1
2 + SD22)1/2. Fold changes were calculated as
–DDCt6SD.
Supporting Information
Text S1 Mathemathical details of the probabilistic models
gMOS and mgMOS
Found at: doi:10.1371/journal.pone.0007144.s001 (0.07 MB
PDF)
Table S1 Genes clustered to Gata3 in OC-1 with a Spearman
correlation of at least 0.800
Found at: doi:10.1371/journal.pone.0007144.s002 (0.04 MB
XLS)
Table S2 Genes clustered to Gata3 in VOT-E36 in serum-free
media with Spearman correlation of at least 0.800
Found at: doi:10.1371/journal.pone.0007144.s003 (0.17 MB
XLS)
Table S3 Genes clustered to Gata3 in VOT-N33 and VOT-E36
cultured in serum, with a Spearman correlation of at least 0.800
Found at: doi:10.1371/journal.pone.0007144.s004 (0.03 MB
XLS)
Table S4 Correlation between gene expression level calculated
by mgMOS and measured by qRT-PCR
Found at: doi:10.1371/journal.pone.0007144.s005 (0.02 MB
XLS)
Figure S1 Analysis of siRNA knock down of gata3 in vitro.
Immunoperoxidase label for gata3 in a control culture and
following treatment with siRNA to gata3 as described in the
methods. The frequency histogram for intensity of nuclear
labelling was derived from measurements made with ImageJ
software. A measurable decrease in intensity was recorded in over
90% of the cell population.
Found at: doi:10.1371/journal.pone.0007144.s006 (3.27 MB TIF)
Figure S2 Relative expression of gata3 and akt2 in gata3+/+
and gata3+/2 mice. Sections through cochlear ducts of gata3+/+
and gata3+/2 mice at E16.5 double-labeled with antibodies to
gata3 and akt2. The images were exposed and reproduced in
parallel under identical conditions. In gata3+/2 mice the label for
both gata3 and akt2 was less intense in most cells in the cochlea.
The lower left panel confirms the overlap between the two labels
in gata3+/+ mice. The lower right panel shows the distribution of
cell nuclei in gata3+/2 mice, highlighting the fact that the few
cells expressing detectable levels of gata3 also labelled for akt2
(arrowheads). Note that the label for akt2 in the cochlear cartilage
(asterisk) was the same for both animals. Akt2 is expressed in many
different cell types, including chondrocytes, but levels were
unaffected in gata3+/2 mice in cells that did not normally
express gata3. Scale bar = 100 mm
Found at: doi:10.1371/journal.pone.0007144.s007 (5.34 MB TIF)
Figure S3 Expression of gata3 and akt2 in gata3+/2 mice.
Sections through cochlear ducts of gata3+/2 mice at E16.5
double-labeled with antibodies to gata3 and akt2. The antibodies
to gata3 were sensitive to tissue fixation and were used at high
concentration in gata3+/2 mice to detect the low levels of gata3.
This caused non-specific label in the basement membrane.
Nevertheless, in separate sections of the cochlea in gata3+/2
mice there was a clear overlap between gata3 and akt2, despite the
much lower expression of both proteins compared to that in
normal mice. Scale bar = 100 mm
Found at: doi:10.1371/journal.pone.0007144.s008 (2.98 MB TIF)
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